Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
3D Genomemedicine Inc is going to operate in USA
Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.
Visit us at MEDICA in Duesseldorf, Germany:
15.11. - 18.11.21
Visit us at BIO CEO & Investor Digital Conference New York, USA:
16.02. - 18.02.2021
Visit us at INVEST in Stuttgart, Germany:
23.03. - 24.04.21
Visit us at LSX World Congress 2021 Virtual London, UK:
01.02 - 05.02.2021
We wish you a merry Christmas and a happy new year 2021
Duisburg, 27.01.2016: Genekam BiotechnologyAG, Germany has developed a highly sensitive DNA test to detect Zika virus. It is spreading across the world and causing infections particularly in pregnant women and it leads to brain related problems, which are not curable at present. Zika virus is a mosquito borne virus as the mosquitoes spread this virus. At present there is no therapy and no vaccine for this virus available, therefore prevention is one possible way to stop this virus.
Genekam Biotechnology AG has developed a kit, which can detect this virus in human samples as well as also in mosquitoes. This kit is economical as the price per test will be around Euro 5-7. Therefore detection is only method, which can help to stop spreading this virus. As it is a DNA test, it is highly sensitive and specific. Moreover one can see the load of this virus.
Genekam Biotechnology AG is specialised on developing ready to use tests for different viruses and other pathogens. Genekam is trying to develop therapeutic molecules to cure various viral diseases along with developing stem cell solutions.
These photoes are free to be used in presswork, social media or other media distribution.